MENU
CHRO
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION
Channel Therapeutics (CHRO) Ownership - Who owns Channel Therapeutics?
Channel Therapeutics Corp is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain... Show more
Profile
Industry
N/A
Address
4400 Route 9 South
Phone
+1 732 514-2636
Employees
7
Web
https://www.chromocell.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
6.84M
P/E Ratio
N/A
Total Cash
1.25M
Projected Growth
N/A
Total Debt
2.29M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.21
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
CHRO
Capitalization
6.84M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
1.26M
Total Cash/Share
0.21
Total Debt
2.29M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-1.43M
P/B Ratio
4.11
Cash Flow
N/A
Earnings
-1.81
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
583
Current Ratio
0.60
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-9.23M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-931.05
Shares Held By Institutions
38.2K
Shares Outstanding - Current
6.1M
Total Liabilities
3.57M
Total Volume MTD
N/A
Value
-1
Gain YTD
70.047
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
4400 Route 9 South
Phone
+1 732 514-2636
Employees
7
Web
https://www.chromocell.com